中国大陆疫苗招标、采购与配送管理实践:一项全国性研究
2019年4月至7月对中国大陆31个省份开展机构问卷调查,评估2018年疫苗招标、采购与配送管理。结果显示各省管理方式存在差异,尤其非免疫规划疫苗;作者认为应针对不同地区制定具体政策和措施以改善免疫管理。
要点
- 31个省份中13个(41.9%)完成国家免疫规划疫苗集中招标,其余省份2018年独立招标采购。
- 所有省份对非免疫规划疫苗实施省级统一招标,其中18个(58.1%)选择省级公共资源交易平台。
核心结论
- 2018年中国大陆疫苗招标、采购与配送管理存在省际差异,非免疫规划疫苗尤为明显。
- 作者认为应针对不同地区制定具体政策和措施,以更好地改善免疫管理。
研究设计与样本
- 机构调查:于2019年4月至7月向中国大陆31个省份发放结构化问卷,收集疫苗招标、采购、配送及相关信息。
主要发现
- 31个省份中13个(41.9%)完成国家免疫规划疫苗集中招标,其余省份2018年独立招标采购。
- 所有省份对非免疫规划疫苗实施省级统一招标,其中18个(58.1%)选择省级公共资源交易平台,但模式各省不同。
- 采购由区级疾病预防控制中心(CDC)承担,但其无法从省级CDC为当地人群选定的过多疫苗中选择最佳选项。
- 国家免疫规划疫苗与非免疫规划疫苗的配送模式在同一省内总体相似,但省际差异很大;主要模式为各级CDC配送约三分之二(64.5%)的国家免疫规划疫苗和超过三分之一(35.5%)的非免疫规划疫苗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To conduct a nationwide evaluation of vaccine bidding, procurement and distribution management for understanding and improving the current situation well in mainland China. METHODS: An institution survey was carried out to collect information on tendering, procurement, distribution and related issues to vaccines by structured questionnaires administered to 31 provinces in mainland China from April to July 2019. RESULTS: In 13 (41.9%) of 31 provinces, centralized bidding of National Immunization Program (NIP) vaccines was accomplished, and others conducted independent tendering and purchasing in 2018. For non-NIP vaccines, all provinces implemented unified bidding at the provincial level and over half (18, 58.1%) of them chose provincial public resource trading platforms, but their modes varied over provinces. Then procurement was undertaken by the district-level centers for disease control and prevention (CDC) while they were unable to choose the best option of too many vaccines targeted by the province-level CDC for local populations. The distribution modes of NIP and non-National Immunization Program (non-NIP) vaccines were similar overall in a province but very different over provinces. Main mode was that CDCs at different levels delivered about two thirds (64.5%) of NIP vaccines distribution and more than one third (35.5%) of non-NIP vaccines. Another distribution mode was occupied as fully buying the service from third parties in 3 municipalities. Some provinces mixed both modes, too. The total distribution volume of vaccines was 430.7 million doses in 2018. The top five non-NIP vaccines delivered in 2018 were human rabies vaccine, varicella vaccine, EV71 hand foot mouth disease vaccine, hepatitis B vaccine and influenza vaccine. CONCLUSION: The vaccine biding, procurement and distribution management varied over provinces in mainland China in 2018, especially for non-NIP vaccines. Specific policies and measures should be developed for different regions to improve the immunization management better.
引用
- Wang W, Wang Y, Wang Y, et al. Vaccine bidding, procurement and distribution management practices in mainland China: A nationwide study. Vaccine. 2021. PMID: 34802784. doi:10.1016/j.vaccine.2021.11.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。